{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T07:15:20Z","timestamp":1771744520339,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,25]]},"DOI":"10.7759\/cureus.34216","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T05:38:59Z","timestamp":1674711539000},"source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan"],"prefix":"10.7759","author":[{"given":"Syeda M","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnoor F","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima H","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30462-8","article-title":"Tackling hepatitis C\u2014Pakistan's road to success","volume":"391","author":"Moin A","year":"2018","unstructured":"Moin A, Fatima H, Qadir TF. Tackling hepatitis C\u2014Pakistan's road to success. Lancet. 2018, 391:834-5. 10.1016\/S0140-6736(18)30462-8","journal-title":"Lancet"},{"key":"ref2","article-title":"National prevalence rate of hepatitis B and C in Pakistan and its risk factors","volume":"28","author":"Mehmood S","year":"2020","unstructured":"Mehmood S, Raza H, Abid F, et al.. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J Public Health. 2020, 28:751-64.","journal-title":"J Public Health"},{"key":"ref3","unstructured":"Pakistan. HIV outbreak in Sindh province. (2019). Accessed: October 25, 2022: https:\/\/www.emro.who.int\/pak\/pakistan-news\/pakistan-hiv-outbreak-in-sindh-province.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02804.x","article-title":"Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms","volume":"51","author":"Weusten J","year":"2011","unstructured":"Weusten J, Vermeulen M, van Drimmelen H, Lelie N. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion. 2011, 51:203-15. 10.1111\/j.1537-2995.2010.02804.x","journal-title":"Transfusion"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1999.0228","article-title":"NAT: perspectives for cellular components","volume":"27","author":"Barbara JAJ","year":"1999","unstructured":"Barbara JAJ. NAT: perspectives for cellular components. Biologicals. 1999, 27:333-6. 10.1006\/biol.1999.0228","journal-title":"Biologicals"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12521","article-title":"Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan","volume":"54","author":"Moiz B","year":"2014","unstructured":"Moiz B, Moatter T, Shaikh U, et al.. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan. Transfusion. 2014, 54:1652-9. 10.1111\/trf.12521","journal-title":"Transfusion"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13017","article-title":"Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan","volume":"55","author":"Niazi SK","year":"2015","unstructured":"Niazi SK, Bhatti FA, Salamat N, Ghani E, Tayyab M. Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan. Transfusion. 2015, 55:1803-11. 10.1111\/trf.13017","journal-title":"Transfusion"},{"key":"ref8","article-title":"Multiplex real-time RT-PCR assay for transfusion transmitted viruses in sero-negative allogeneic blood donors: an experience from Southern Pakistan","volume":"39","author":"Sultan S","year":"2017","unstructured":"Sultan S, Nasir MI, Rafiq S, et al.. Multiplex real-time RT-PCR assay for transfusion transmitted viruses in sero-negative allogeneic blood donors: an experience from Southern Pakistan. Malays J Pathol. 2017, 39:149.","journal-title":"Malays J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3787","article-title":"Transfusion transmissible infections: maximizing donor surveillance","volume":"10","author":"Awan SA","year":"2018","unstructured":"Awan SA, Junaid A, Sheikh S. Transfusion transmissible infections: maximizing donor surveillance. Cureus. 2018, 10:e3787. 10.7759\/cureus.3787","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch MP","year":"2005","unstructured":"Busch MP, Glynn SA, Stramer SL, et al.. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005, 45:254-64. 10.1111\/j.1537-2995.2004.04215.x","journal-title":"Transfusion"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00773.x","article-title":"Hepatitis B virus blood screening: unfinished agendas","volume":"91","author":"Comanor L","year":"2006","unstructured":"Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang. 2006, 91:1-12. 10.1111\/j.1423-0410.2006.00773.x","journal-title":"Vox Sang"},{"key":"ref12","article-title":"Multiplex HIV, HCV & HBV nucleic acid test for use on the cobas\u00ae 6800\/8800 Systems","author":"FDA","year":"2020","unstructured":"FDA. Multiplex HIV, HCV & HBV nucleic acid test for use on the cobas\u00ae 6800\/8800 Systems. cobas\u00ae MPX. 2020,","journal-title":"cobas\u00ae MPX"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12923","article-title":"Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield\/window period model in an Indian setting","volume":"32","author":"Pandey HC","year":"2022","unstructured":"Pandey HC, Varghese M, Rana A, Kumar R, Jain P. Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield\/window period model in an Indian setting. Transfus Med. 2022, 32:492-8. 10.1111\/tme.12923","journal-title":"Transfus Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2017.03.010","article-title":"Residual risk of HIV, HCV and HBV in Canada","volume":"56","author":"O'Brien SF","year":"2017","unstructured":"O'Brien SF, Yi QL, Fan W, Scalia V, Goldman M, Fearon MA. Residual risk of HIV, HCV and HBV in Canada. Transfus Apher Sci. 2017, 56:389-91. 10.1016\/j.transci.2017.03.010","journal-title":"Transfus Apher Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12058","article-title":"Transfusion\u2010transmitted infections: testing strategies and residual risk","volume":"9","author":"Dodd R","year":"2014","unstructured":"Dodd R. Transfusion\u2010transmitted infections: testing strategies and residual risk. ISBT Science Series. 2014, 9:1-5. 10.1111\/voxs.12058","journal-title":"ISBT Science Series"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1111\/trf.13024","article-title":"Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions","volume":"55","author":"Bruhn R","year":"2015","unstructured":"Bruhn R, Lelie N, Busch M, Kleinman S,  International NAT Study Group. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions. Transfusion. 2015, 55:1195-205.","journal-title":"Transfusion"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13024","article-title":"Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions","volume":"55","author":"Bruhn R","year":"2015","unstructured":"Bruhn R, Lelie N, Busch M, Kleinman S. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions. Transfusion. 2015, 55:1195-205. 10.1111\/trf.13024","journal-title":"Transfusion"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12694","article-title":"Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors","volume":"54","author":"Stolz M","year":"2014","unstructured":"Stolz M, Tinguely C, Fontana S, Niederhauser C. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors. Transfusion. 2014, 54:2961-7. 10.1111\/trf.12694","journal-title":"Transfusion"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13819","article-title":"Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing","volume":"57","author":"Lelie N","year":"2017","unstructured":"Lelie N, Bruhn R, Busch M, Vermeulen M, Tsoi WC, Kleinman S. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing. Transfusion. 2017, 57:24-35. 10.1111\/trf.13819","journal-title":"Transfusion"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188066","article-title":"Detection of HBsAg mutants in the blood donor population of Pakistan","volume":"12","author":"Farooq A","year":"2017","unstructured":"Farooq A, Waheed U, Zaheer HA, Aldakheel F, Alduraywish S, Arshad M. Detection of HBsAg mutants in the blood donor population of Pakistan. PLoS One. 2017, 12:e0188066. 10.1371\/journal.pone.0188066","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000457965","article-title":"Three-year experience in NAT screening of blood donors for transfusion transmitted viruses in Croatia","volume":"44","author":"Safic Stanic H","year":"2017","unstructured":"Safic Stanic H, Babic I, Maslovic M, et al.. Three-year experience in NAT screening of blood donors for transfusion transmitted viruses in Croatia. Transfus Med Hemother. 2017, 44:415-20. 10.1159\/000457965","journal-title":"Transfus Med Hemother"},{"key":"ref22","article-title":"Yield of NAT screening in Slovenia","volume":"81","author":"Stezinar SL","year":"2012","unstructured":"Stezinar SL, Nogra\u0161ek P. Yield of NAT screening in Slovenia. Slov Med J. 2012, 81:","journal-title":"Slov Med J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07279-5","article-title":"The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields\u00a0from a single blood center in China with 10-years review","volume":"22","author":"Wu D","year":"2022","unstructured":"Wu D, Feng F, Wang X, et al.. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields\u00a0from a single blood center in China with 10-years review. BMC Infect Dis. 2022, 22:279. 10.1186\/s12879-022-07279-5","journal-title":"BMC Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.03.004","article-title":"Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India","volume":"49","author":"Agarwal N","year":"2013","unstructured":"Agarwal N, Chatterjee K, Coshic P, Borgohain M. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India. Transfus Apher Sci. 2013, 49:482-4. 10.1016\/j.transci.2013.03.004","journal-title":"Transfus Apher Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2010.09.013","article-title":"Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? a prospective study, the results of 18,200 blood donors from the Turkish Red Crescent","volume":"43","author":"Kosan E","year":"2010","unstructured":"Kosan E, Kocazeybek B, Altunay H, et al.. Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? a prospective study, the results of 18,200 blood donors from the Turkish Red Crescent. Transfus Apher Sci. 2010, 43:269-72. 10.1016\/j.transci.2010.09.013","journal-title":"Transfus Apher Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1988.4.149","article-title":"Human immunodeficiency virus-associated disorders in Pakistan","volume":"4","author":"Khanani RM","year":"1988","unstructured":"Khanani RM, Hafeez A, Rab SM, Rasheed S. Human immunodeficiency virus-associated disorders in Pakistan. AIDS Res Hum Retroviruses. 1988, 4:149-54. 10.1089\/aid.1988.4.149","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3201\/eid2704.204205","article-title":"Systematic review of reported HIV outbreaks, Pakistan, 2000-2019","volume":"27","author":"Rabold EM","year":"2021","unstructured":"Rabold EM, Ali H, Fernandez D, et al.. Systematic review of reported HIV outbreaks, Pakistan, 2000-2019. Emerg Infect Dis. 2021, 27:1039-47. 10.3201\/eid2704.204205","journal-title":"Emerg Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01813.x","article-title":"Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey","volume":"48","author":"Velati C","year":"2008","unstructured":"Velati C, Roman\u00f2 L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008, 48:2205-13. 10.1111\/j.1537-2995.2008.01813.x","journal-title":"Transfusion"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12770","article-title":"Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015)","volume":"114","author":"Fiedler SA","year":"2019","unstructured":"Fiedler SA, Oberle D, Chudy M, et al.. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015). Vox Sang. 2019, 114:443-50. 10.1111\/vox.12770","journal-title":"Vox Sang"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00311.x","article-title":"Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing","volume":"85","author":"Fang CT","year":"2003","unstructured":"Fang CT, Field SP, Busch MP, Heyns Adu P. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sang. 2003, 85:9-19. 10.1046\/j.1423-0410.2003.00311.x","journal-title":"Vox Sang"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/133426-effectiveness-of-using-nucleic-acid-amplification-test-to-screen-blood-donors-for-hepatitis-b-hepatitis-c-and-hiv-a-tertiary-care-hospital-experience-from-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:49Z","timestamp":1707508669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/133426-effectiveness-of-using-nucleic-acid-amplification-test-to-screen-blood-donors-for-hepatitis-b-hepatitis-c-and-hiv-a-tertiary-care-hospital-experience-from-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.34216","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,25]]}}}